Inicio › Glioma difuso intrínseco de la protuberancia › Ohio
Ensayos clínicos de Glioma difuso intrínseco de la protuberancia en Ohio
12 estudios sobre Glioma difuso intrínseco de la protuberancia buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
12 Months – 39 Years · Todos los sexos · Actualizado el 21 sept 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoFase 1/2
12 Months – 21 Years · Todos los sexos · Actualizado el 11 sept 2026 · NCT04870944Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoEstudio observacional
12 Months – 39 Years · Todos los sexos · Actualizado el 8 sept 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 12 a 39 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 3 a 39 · Todos los sexos · Actualizado el 24 ago 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 1 a 26 · Todos los sexos · Actualizado el 4 ago 2026 · NCT07680439Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1/2
Edades de 4 a 39 · Todos los sexos · Actualizado el 20 jul 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
Edades de 1 a 21 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 2 a 39 · Todos los sexos · Actualizado el 26 jun 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 2
12 Months – 39 Years · Todos los sexos · Actualizado el 29 may 2026 · NCT05843253A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
ReclutandoFase 1 temprana
Hasta los 21 · Todos los sexos · Actualizado el 18 mar 2026 · NCT04655404International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 20 oct 2025 · NCT03101813De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.